Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zhi Wei Teh"'
Autor:
Ee Vien Low, Mohan Dass Pathmanathan, Yi Yang Ten, Suresh Kumar Chidambaram, Wee Ric Kim, Wei Jia Lee, Zhi Wei Teh, Maheshwara Rao Appannan, Mastura Ismail, Azah Abdul Samad, Kalaiarasu M. Peariasamy
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The effect of nirmatrelvir/ritonavir on preventing post-COVID condition (PCC) in the BA4, BA5, and XBB Omicron predominant periods is not well understood. The purpose of this study was to assess how nirmatrelvir/ritonavir treatmen
Externí odkaz:
https://doaj.org/article/bee5dbb338f14b44a6e178ea6248f6a9
Autor:
Ee Vien Low, Hoon Shien Teh, Nicholas Yee Liang Hing, Suresh Kumar Chidambaram, Mohan Dass Pathmanathan, Wee Ric Kim, Wei Jia Lee, Zhi Wei Teh, Maheshwara Rao Appannan, Shahanizan Mohd Zin, Faizah Muhamad Zin, Samha Bashirah Mohamed Amin, Mastura Ismail, Azah Abdul Samad, Kalaiarasu M. Peariasamy
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 2, Pp 299-308 (2024)
Abstract Background and objectives Nirmatrelvir/ritonavir was administered orally to manage mild to moderate symptoms of COVID-19 in adult patients. The objectives of this study were to (i) evaluate the cost-effectiveness of prescribing nirmatrelvir/
Externí odkaz:
https://doaj.org/article/31319d65f6fd40fd95597e28ebde83e5
Autor:
Ee Vien Low, Mohan Dass Pathmanathan, Suresh Kumar Chidambaram, Wee Ric Kim, Wei Jia Lee, Zhi Wei Teh, Maheshwara Rao Appannan, Shahanizan Mohd Zin, Faizah Muhamad Zin, Samha Bashirah Mohamed Amin, Mastura Ismail, Azah Abdul Samad, Kalaiarasu M. Peariasamy
Publikováno v:
International Journal of Infectious Diseases, Vol 135, Iss , Pp 77-83 (2023)
Objective: To determine if nirmatrelvir-ritonavir 300mg/100mg treatment for 5 days in high-risk outpatients with mild to moderate COVID-19 symptoms was associated with a reduction in hospitalization, intensive care unit (ICU) admission, and death. Me
Externí odkaz:
https://doaj.org/article/27c56797ab36449ba2c03c2a4e16f77c
Autor:
Nai Ming Lai, Sheng Xuan Wai, Roger Soll, Yin Sear Lim, Colleen Ovelman, Min Yao Chan, Zhi Wei Teh, Shaun Wen Huey Lee
Publikováno v:
Neonatology. 117:687-693
Background: Neonates with jaundice are usually managed according to their serum bilirubin despite an unclear overall correlation between bilirubin levels and patient-important outcomes (PIOs) such as kernicterus spectrum disorder (KSD). Objectives: W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0851739436f812ac0c949e235151e56e
https://doi.org/10.1159/000511656
https://doi.org/10.1159/000511656